PMDA:Top Safety Measures
https://www.pmda.go.jp/
PMDA RSS FeedenMHLW Pharmaceuticals and Medical Devices Safety Information No.408
https://www.pmda.go.jp/english/safety/info-services/drugs/medical-safety-information/0021.html
Pharmaceuticals and Medical Devices Agency2024-03-14T12:00:00+09:00PMDA Risk Communication: Axicabtagene ciloleucel, etc. posted
https://www.pmda.go.jp/english/safety/info-services/ctp/0006.html
Pharmaceuticals and Medical Devices Agency2024-03-01T12:00:00+09:00Notifications Related to Safety Measures (In-vitro Diagnostics) : Points to Consider, etc. for Consultation Associated With Revision, etc. of Package Inserts, etc. posted
https://www.pmda.go.jp/english/safety/info-services/in-vitro/0004.html
Pharmaceuticals and Medical Devices Agency2024-02-29T12:00:00+09:00Notifications Related to Safety Measures (Regenerative Medical Products): Points to Consider, etc. for Consultation Associated With Revision, etc. of Package Inserts, etc. posted
https://www.pmda.go.jp/english/safety/info-services/ctp/0003.html
Pharmaceuticals and Medical Devices Agency2024-02-29T12:00:00+09:00Notifications Related to Safety Measures (Medical Devices) : Points to Consider, etc. for Consultation Associated With Revision, etc. of Package Inserts, etc. posted
https://www.pmda.go.jp/english/safety/info-services/devices/0007.html
Pharmaceuticals and Medical Devices Agency2024-02-29T12:00:00+09:00Notifications Related to Safety Measures (Drugs): Points to Consider, etc. for Consultation Associated With Revision, etc. of Package Inserts, etc. posted
https://www.pmda.go.jp/english/safety/info-services/drugs/safety-measures/0001.html
Pharmaceuticals and Medical Devices Agency2024-02-29T12:00:00+09:00Revisions of PRECAUTIONS: Topiramate, etc. posted
https://www.pmda.go.jp/english/safety/info-services/drugs/revision-of-precautions/0011.html
Pharmaceuticals and Medical Devices Agency2024-02-15T12:00:00+09:00